This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Bunzl (BNZL.L) - revenue growth for H1 period is expected to be approximately 6%, due to underlying revenue growth of about 2% and the positive impact of acquisitions. Closing price 1630p. (Reuters)
Glaxosmithkline (GSK.L) - A plant of the drug maker in Canada that makes the flu vaccine Flulaval has been cited by the U.S. Food and Drug Administration for failing to meet quality control standards. Closing price 1576p. (Reuters)
Aberdeen Asset Management (ADN.L) - Sees greater than forecast savings from its recent SWIP acquisition and expects to raise its dividend this year, as well as seeing scope to buy back shares, its chief executive said. Closing price 439.6p. (Reuters)
BHP Billiton, Antofagasta, Rio Tinto (BLT.L), (ANTO.L), (RIO.L) - London copper was treading water near a three-week high, underpinned by dwindling global exchange stocks, while summer holidays in the northern hemisphere curbed trading. Closing prices 1921.5p, 779p, 3096p. (Reuters)
Shire (SHP.L) Is seeking to defend itself after receiving a $46bn approach from U.S. group AbbVie, said on Wednesday a U.S. court had endorsed its patents on top-selling hyperactivity drug Vyvanse. Closing Price 4404p (Reuters)
Balfour Beatty (BALF.L) Joint venture receives instruction for third phase of Sellafield nuclear facility contract valued at £160 million. Closing Price 229.30p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Chemring Group Plc | CHG.L | -8.43% | -2.17% | -12.53% |
| Imagination Technologies Group Plc | IMG.L | 7.71% | 8.95% | 0.64% |
| BHP Billiton | BLT.L | -0.85% | 0.57% | -1.37% |
| Petrofac | PFC.L | -1.77% | 1.53% | -2.81% |
| Croda International Plc | CRDA.L | -9.06% | -6.36% | -10.76% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research